Skip to main content
Clinical Trials/NCT04377737
NCT04377737
Withdrawn
Not Applicable

Incidence of Covid-19 in School Children During the Pandemic Period in Nice

Fondation Lenval1 site in 1 countryMay 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infection; Viral, Coronavirus
Sponsor
Fondation Lenval
Locations
1
Primary Endpoint
evaluation of the prevalence of positive real-time-polymerase chain reaction (rt-PCR) in school children during the pandemic period in Nice
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The Coronavirus disease 2019 (COVID-19) is causing a global pandemic with high morbidity and mortality among adults and mainly the elderly. Children seem to be little or not affected by this infection. It is estimated that children could be asymptomatic or pauci-symptomatic carriers and thus be vectors of the disease. This is why measures to close schools and confine populations have been decreed in a large number of countries, including France. However, there are only a few data on the prevalence of COVID19 disease in children. The deconfinement strategy depends on data on the prevalence of the disease, especially in children.

Investigators propose to evaluate the incidence of Covid-19 in preschool and elementary schools children in the city of Nice (South of France) during the pandemic period using a local prospective study of 914 children

Detailed Description

The Coronavirus disease 2019 (COVID-19) is causing a global pandemic with high morbidity and mortality among adults and mainly the elderly. Children seem to be little or not affected by this infection. It is estimated that children could be asymptomatic or pauci-symptomatic carriers and thus be vectors of the disease. However, the role of the children in the spread of COVID-19 injection remains unclear. Measures to close schools and to confine populations have been decreed in a large number of countries, including France. This decision has been based on epidemiologic data of other viral infections having droplet transmission and on data of Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) asymptomatic portage. Furthermore, there are only a few data on the prevalence of COVID19 disease in children. The deconfinement strategy depends on data on the prevalence of the disease, especially in children. Therefore, investigators propose to evaluate the incidence of Covid-19 in preschool and elementary schools children in the city of Nice (South of France) during the pandemic period using a local prospective study of 914 children. This study will start on 11th May 2020, date of school reopening, in order to collect epidemiologic data about Covid-19 carriage among schoolers and to support governmental strategy for the new school year in September 2020.

Registry
clinicaltrials.gov
Start Date
May 15, 2020
End Date
September 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Fondation Lenval
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ranging from 3 to 10 years old
  • Children attending to school in Nice
  • Informed consent
  • French insurance subscribed

Exclusion Criteria

  • Refusal to participate from the parents or the child
  • Bleeding disorders

Outcomes

Primary Outcomes

evaluation of the prevalence of positive real-time-polymerase chain reaction (rt-PCR) in school children during the pandemic period in Nice

Time Frame: at 42 days

measure by two rt-PCR COVID-19 tests regardless the serological status of the child

Secondary Outcomes

  • evaluation of the serological prevalence of the Covid-19 infection(at inclusion and at 42 days)
  • comparison of inflammatory response level between different coronavirus strains(at 42 days)
  • evaluation of the COVID-19 reinfection among seropositive children at the inclusion time(at inclusion and at 42 days)
  • Estimation of medico-social risk factors associated with COVID-19 infection(at 42 days)
  • evaluation of the prevalence of positive rt-PCR of other respiratory viruses (including others coronavirus)(at 42 days)

Study Sites (1)

Loading locations...

Similar Trials